INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 103 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $6,361,000 | +110.6% | 1,969,225 | +1.7% | 0.24% | +75.0% |
Q3 2016 | $3,020,000 | +17.3% | 1,935,942 | 0.0% | 0.14% | +38.6% |
Q2 2016 | $2,575,000 | -88.9% | 1,935,942 | -56.0% | 0.10% | -89.8% |
Q1 2016 | $23,182,000 | -31.4% | 4,398,862 | +2.2% | 0.99% | -28.0% |
Q4 2015 | $33,797,000 | +2.3% | 4,305,288 | +10.1% | 1.37% | +7.2% |
Q3 2015 | $33,046,000 | +22.4% | 3,910,721 | +58.6% | 1.28% | +42.2% |
Q2 2015 | $26,993,000 | -51.3% | 2,465,129 | -37.9% | 0.90% | -50.0% |
Q1 2015 | $55,475,000 | -14.9% | 3,968,155 | +2.9% | 1.80% | -23.2% |
Q4 2014 | $65,158,000 | +25.0% | 3,857,805 | -0.6% | 2.34% | +23.3% |
Q3 2014 | $52,107,000 | +11.3% | 3,882,805 | +5.7% | 1.90% | +0.8% |
Q2 2014 | $46,817,000 | -11.4% | 3,674,838 | -17.3% | 1.88% | -12.7% |
Q1 2014 | $52,839,000 | -8.5% | 4,444,027 | +6.3% | 2.16% | -27.9% |
Q4 2013 | $57,750,000 | +52.6% | 4,181,743 | +92.6% | 2.99% | +69.9% |
Q3 2013 | $37,853,000 | -0.7% | 2,171,744 | -7.8% | 1.76% | -2.0% |
Q2 2013 | $38,132,000 | – | 2,354,963 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
Bleichroeder LP | 250,000 | $530,000 | 0.10% |
PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |